# CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study

> **NCT00801710** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 42 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Chronic Total Occlusion

## Interventions

- **DEVICE:** BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire)

## Key facts

- **NCT ID:** NCT00801710
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-06
- **Final completion:** 2009-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801710, "CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00801710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*